Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
Gilles R Dagenais, Leanne Dyal, Jacqueline J Bosch, Darryl P Leong, Victor Aboyans, Scott D Berkowitz, Deepak L Bhatt, Stuart J Connolly, Keith A A Fox, Eva Muehlhofer, Jeffrey L Probstfield, Petr Widimsky, Bernhard R Winkelmann, Salim Yusuf, John W Eikelboom
Heart Jul 2021, 107 (14) 1130-1137; DOI: 10.1136/heartjnl-2020-318758
